Figure 3From: Endocrine disruptor screening: regulatory perspectives and needsProposed modular test platform. To identify and assess the endocrine potential of environmental samples using a combination of in vivo and in vivo bioassays. Dotted boxes refer to optional tests (redrawn and adapted from Kase et al. [56]).Back to article page